(Q35920722)

11 August 2017

1 reference

title

Management of gastroduodenopathy associated with use of nonsteroidal anti-inflammatory drugs (English)

1 reference

11 August 2017

D. S. Loeb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548951

7 October 2022

D. A. Ahlquist

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548951

7 October 2022

N. J. Talley

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1548951

7 October 2022

language of work or name

English

0 references

publication date

1 April 1992

1 reference

11 August 2017

1 reference

11 August 2017

67

1 reference

11 August 2017

4

1 reference

11 August 2017

354-364

1 reference

Utilization of nonsteroidal antiinflammatory drugs

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Nonsteroidal anti-inflammatory drugs and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Peptic ulcer and non-steroidal anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Non-steroidal anti-inflammatory drugs and peptic ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Smoking, nonsteroidal anti-inflammatory drugs, and acetaminophen in gastric ulcer. A study of associations and of the effects of previous diagnosis on exposure patterns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Fatal peptic ulcer complications and the use of non-steroidal anti-inflammatory drugs, aspirin, and corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND HOSPITAL ADMISSION FOR PERFORATED PEPTIC ULCER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Non-steroidal anti-inflammatory drugs and peptic ulcer perforation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Risk and cost of gastrointestinal side effects associated with nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Certain nonsteroidal antiinflammatory drugs and hospitalization for upper gastrointestinal bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Non-steroidal anti-inflammatory drug associated ulcer: Epidemiology, causation and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Trends in peptic ulcer surgery. A population-based study in Rochester, Minnesota, 1956-1985

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

"Diaphragm-like" strictures of the small bowel in patients treated with non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Nonsteroidal antiinflammatory drug-induced colonic strictures: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Ano-rectal lesions in patients taking suppositories containing non-steroidal anti-inflammatory drugs (NSAID)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Mechanisms of nonsteroidal anti-inflammatory drug-induced gastric damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Mechanisms of Gastric Mucosal Protection: A Role for the ‘Mucus-Bicarbonate’ Barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Comparison of prostacyclin and prostaglandin E2 on gastric secretion, gastrin release, and mucosal blood flow in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Misoprostol reduces gastroduodenal injury from one week of aspirin: an endoscopic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Gastrointestinal ulcer formation in rabbits immunized with prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Gastroduodenal ulceration in rabbits producing antibodies to prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Effect of indomethacin on basal and histamine stimulated human gastric acid secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

Gastric cytoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

The pathophysiology of peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

The effect of chronic aspirin use on duodenal and gastric ulcer hospitalizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Symptoms in patients with peptic ulcer and hematemesis and/or melena related to the use of non-steroid anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Rising frequency of ulcer perforation in elderly people in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Absence of abdominal pain in elderly patients with peptic ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Which peptic ulcer patients bleed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

A multicenter study of hospitalization in rheumatoid arthritis. Frequency, medical-surgical admissions, and charges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Final report on the aspirin component of the ongoing Physicians' Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Role of H2-receptor blockers in the prevention of gastric injury resulting from nonsteroidal anti-inflammatory agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Gastric adaptation occurs with aspirin administration in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

Aspirin and the stomach

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Ulcer complications and nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

NSAIDs--should every prescription carry a government health warning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Pathogenesis of peptic ulcer and implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Helicobacter pylori and peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Helicobacter pylori: controversies and an approach to management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

The interaction between Helicobacter pylori culture filtrate and indomethacin: effects on the integrity of human gastric antral mucosa and its prostaglandin E2 production in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo or indomethacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Damage and protection of the human gastric mucosa. A multiparameter assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Survival, prognosis, and causes of death in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Alcohol, Aspirin, and Gastrointestinal Bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Influence of aspirin and ethanol on fecal blood levels as determined by using the HemoQuant assay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

HemoQuant, a new quantitative assay for fecal hemoglobin. Comparison with Hemoccult

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Fecal blood levels in health and disease. A study using HemoQuant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Double-contrast barium meal and upper gastrointestinal endoscopy. A comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Healing of Aspirin-Associated Peptic Ulcer Disease Despite Continued Salicylate Ingestion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Peptic ulcer in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin. A double-blind study with cimetidine and follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Treatment of gastric ulcer with enprostil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Prostaglandins for peptic ulcer: a promise unfulfilled

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Chemistry and synthetic development of misoprostol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Misoprostol clinical pharmacology. Establishment of activity in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Therapeutic aspects of prostaglandins in the treatment of peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Perspective on the gastric antisecretory effects of misoprostol in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Effects of misoprostol on gastric acid and mucus secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Stimulation of duodenal bicarbonate secretion by misoprostol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Prophylactic and therapeutic role of rioprostil in NSAIDs induced gastroduodenal lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Prostaglandin protection against hemorrhage-induced gastric stress ulceration in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Interim results of a multicenter international comparison of misoprostol and cimetidine in the treatment of out-patients with benign gastric ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Overview of clinical safety with misoprostol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

A multicenter international controlled comparison of two dosage regimes of misoprostol and cimetidine in the treatment of duodenal ulcer in out-patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Misoprostol in the treatment of duodenal ulcer. A multicenter double-blind placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Efficacy of misoprostol (twice daily dosage) in acute healing of duodenal ulcer. A multicenter double-blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Comparison of enprostil and cimetidine in active duodenal ulcer disease. Summary of pooled European studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Comparative efficacy of misoprostol and cimetidine in the treatment of acute duodenal ulcer. Results of major studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Misoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy. A placebo-controlled, multicenter, double-blind, randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Cimetidine therapy in nonsteroidal anti-inflammatory drug gastropathy. Double-blind long-term evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Protective effect of sucralfate against aspirin-induced damage to the human gastric mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Sucralfate treatment of nonsteroidal anti-inflammatory drug-induced gastrointestinal symptoms and mucosal damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Gastric protection by misoprostol against 1,300 mg of aspirin. An endoscopic dose-response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Protection by misoprostol against naproxen-induced gastric mucosal damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

A double-blind study of prophylactic effect of misoprostol on lesions of gastric and duodenal mucosa induced by oral administration of tolmetin in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Sucralfate and cimetidine as maintenance treatment in the prevention of duodenal ulcer recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Role of maintenance sucralfate in prevention of duodenal ulcer recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Economic evaluation of gastric ulcer prophylaxis in patients with arthritis receiving non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Chronic peptic ulceration and nonsteroidal anti-inflammatory drugs: more to be said about NSAIDs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

Silent peptic ulceration: deadly silence or golden silence?

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

Gastrointestinal intolerance and bleeding with non-narcotic analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

Prostaglandin treatment for peptic ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961552-3

7 January 2021

10.1016/S0025-6196(12)61552-3

Identifiers

DOI

1 reference

11 August 2017

1 reference